Facts About HRT Tibolone

HRT is the abbreviated form of hormone replacement therapy. The estrogen levels in a woman falls after menopause causing problems like dryness in vagina, hot flushes and night sweats. To find relieve from these symptoms, a woman may adhere to treatment. treatment may also be taken in those who are at a high risk of osteoporosis or even as a treatment of osteoporosis. In HRT, synthetic hormones are given to the body of the woman.

What is tibolone?
Tibolone is a synthetic steroid, which has progestogenic and some androgenic properties as well as estrogenic effects. Since it has the effects of all three groups of hormones produced by the ovaries (the female gonads) it has been called as gonadomimetic. It has the advantages of other treatments whilst allowing bleed-free hormone replacement treatment for postmenopausal women. However a little irregular bleeding for up to 4-6 months in 10% of patients is a possibility?

What is tibolone used in for?
Tibolone is licensed for treating of menopausal symptoms like hot flushes and also for the decreased libido at this time. From March 1997, tiboloneuse is permitted in prevention of osteoporosis in postmenopausal women. As tibolone does not stimulate endometrial tissue at any site, it is more useful for patients with a past history of endometriosis

Does tibolone have any symptoms?
Tibolone isn�t prescribed in cases where there is a hormone dependant tumour such as breast cancer, a history of heart attacks, liver disorders, strokes and in vaginal bleeding without any specific cause.

Also special care needs to be taken in relation to patients with kidney diseases, epilepsy, migraine, diabetes or high cholesterol levels.

Also, tibolone could also interact with few other drugs like anti-coagulants and some anti-TB and anti-epileptic drugs.

Generally users do not experience any problems when taking HRT tibolone but it has some mild androgenic properties, which may cause greasy skin or even extra hair growth. Breast tenderness, which is a common symptom in normal treatment, is rare when on tibolone.

The need to be monitored during tibolone treatment �
Once they start the therapy, women should be seen and reviewed after three monthes and later once a year if they are settled on a product. The reviewing procedure varies and there is no one criteria for this purpose.